Invesco Ltd. Bridge Bio Pharma, Inc. Transaction History

Invesco Ltd.

$516 Billion
Q4 2024

A detailed history of Invesco Ltd. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 893,127 shares of BBIO stock, worth $31.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

893,127

Previous 857,457 4.16%

Holding current value

$31.2 Million

Previous $21.8 Million 12.26%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$22.35 - $29.5 $797,224 - $1.05 Million	35,670 Added 4.16%	893,127 $24.5 Million
Q3 2024 Nov 12, 2024	SELL	$23.91 - $31.3 $5.53 Million - $7.24 Million	-231,263 Reduced 21.24%	857,457 $21.8 Million
Q2 2024 Aug 13, 2024	BUY	$23.0 - $31.04 $2.07 Million - $2.8 Million	90,095 Added 9.02%	1,088,720 $27.6 Million
Q1 2024 May 14, 2024	SELL	$27.35 - $40.45 $7.49 Million - $11.1 Million	-273,911 Reduced 21.52%	998,625 $30.9 Million
Q4 2023 Feb 12, 2024	BUY	$24.02 - $43.89 $2.7 Million - $4.93 Million	112,383 Added 9.69%	1,272,536 $51.4 Million
Q3 2023 Nov 13, 2023	BUY	$16.89 - $35.01 $8.03 Million - $16.7 Million	475,684 Added 69.5%	1,160,153 $30.6 Million
Q2 2023 Aug 11, 2023	BUY	$13.29 - $18.01 $8.39 Million - $11.4 Million	631,161 Added 1183.99%	684,469 $11.8 Million
Q1 2023 May 12, 2023	BUY	$7.17 - $18.55 $76,582 - $198,132	10,681 Added 25.06%	53,308 $883,000
Q4 2022 Feb 13, 2023	SELL	$6.74 - $11.52 $1.86 Million - $3.18 Million	-276,255 Reduced 86.63%	42,627 $324,000
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $2.19 Million - $3.41 Million	275,673 Added 638.0%	318,882 $3.17 Million
Q2 2022 Aug 15, 2022	SELL	$5.21 - $12.14 $5,111 - $11,909	-981 Reduced 2.22%	43,209 $392,000
Q1 2022 May 16, 2022	SELL	$7.34 - $17.16 $26,783 - $62,616	-3,649 Reduced 7.63%	44,190 $449,000
Q4 2021 Feb 14, 2022	SELL	$11.38 - $53.41 $57,207 - $268,492	-5,027 Reduced 9.51%	47,839 $798,000
Q3 2021 Nov 15, 2021	BUY	$46.87 - $64.24 $290,922 - $398,737	6,207 Added 13.3%	52,866 $2.48 Million
Q2 2021 Aug 17, 2021	BUY	$46.47 - $63.93 $1.03 Million - $1.42 Million	22,185 Added 90.65%	46,659 $2.85 Million
Q1 2021 May 17, 2021	SELL	$55.47 - $72.35 $668,857 - $872,396	-12,058 Reduced 33.01%	24,474 $1.51 Million
Q4 2020 Feb 16, 2021	BUY	$38.38 - $71.11 $1.18 Million - $2.18 Million	30,631 Added 519.08%	36,532 $2.6 Million
Q3 2020 Nov 16, 2020	BUY	$27.2 - $42.19 $160,507 - $248,963	5,901 New	5,901 $222,000
Q2 2020 Aug 14, 2020	SELL	$22.22 - $35.69 $217,578 - $349,476	-9,792 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$16.11 - $36.23 $47,379 - $106,552	2,941 Added 42.93%	9,792 $284,000
Q4 2019 Feb 14, 2020	BUY	$17.96 - $46.63 $123,043 - $319,462	6,851 New	6,851 $240,000

Others Institutions Holding BBIO

# of Institutions

321

Shares Held

176M

Call Options Held

13M

Put Options Held

2.48M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $5.17B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account